Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
about
In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6.Stratification of disease progression in a broad spectrum of degenerative cerebellar ataxias with a clustering method using MRI-based atrophy rates of brain structures.Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study.Valid and efficient manual estimates of intracranial volume from magnetic resonance imagesChange in the cortical complexity of spinocerebellar ataxia type 3 appears earlier than clinical symptomsThe merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type.WDR73 Mutations Cause Infantile Neurodegeneration and Variable Glomerular Kidney Disease.Free-water and free-water corrected fractional anisotropy in primary and premotor corticospinal tracts in chronic stroke.Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6.Consensus paper: radiological biomarkers of cerebellar diseasesMRI-based cerebellar volume measurements correlate with the International Cooperative Ataxia Rating Scale score in patients with spinocerebellar degeneration or multiple system atrophy.CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.Degenerative Ataxias: challenges in clinical research.Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.MR Imaging in Spinocerebellar Ataxias: A Systematic Review.Fast Progression of Cerebellar Atrophy in PLA2G6-Associated Infantile Neuronal Axonal Dystrophy.Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.Effects of transcranial direct current stimulation on grip force control in patients with cerebellar degeneration.Brain MRI Pattern Recognition Translated to Clinical Scenarios.Polyglutamine spinocerebellar ataxias - from genes to potential treatments.Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.MED20 mutation associated with infantile basal ganglia degeneration and brain atrophy.Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research.Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.Longitudinal magnetic resonance imaging study shows progressive pyramidal and callosal damage in Friedreich's ataxia.Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.The cerebral metabolic topography of spinocerebellar ataxia type 3.Histogram analysis of DTI-derived indices reveals pontocerebellar degeneration and its progression in SCA2.Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxiaUnique degeneration signatures in the cerebellar cortex for spinocerebellar ataxias 2, 3, and 7
P2860
Q28391815-4FB27645-9B72-4A52-9843-6D7CD16AEF44Q31111140-F6089647-654A-4D5E-A7AF-B2C0A6B87DC1Q33858639-0A3F4190-CE11-45ED-9018-11ACF0B375C8Q35107256-D624E622-BB66-4476-AA4B-DCB2E15979C7Q35131872-BA359B45-289D-4F2C-83A2-FBDA51CEC469Q35511600-4402E72B-CA21-4FC9-8516-0BDA5D0A3072Q36003277-CBB986B6-CA4C-467E-999A-8CE117F75504Q36193298-E09FB794-9F1F-4B6C-B8FC-52ED4B24070AQ36394845-C390BF61-DD33-4C7C-9698-0CCD32C26A64Q36982906-A0614E51-900C-4A61-BA39-E1CE31F394D0Q37058210-54274B30-8F6F-476A-A8DA-205448D9D310Q37182206-E5525940-0E35-4ED5-A576-020B6A7829F1Q37464905-A875EA8E-2EF4-479B-95CC-DFB47653DBD8Q37572929-F9CA5028-213F-49D6-BC73-5A6940EE89ADQ37619548-F7EEA443-363C-4462-BE26-9D776D7F45E8Q38833094-FC7FF223-7707-4DED-B31E-86892904B702Q39018722-0095E862-CAF3-437B-A7FA-9291F1F08457Q41146062-E28D6DA2-07C2-40DD-A0DD-07C2F034847CQ41712617-6CE86ADD-3628-4CC3-82C3-600BBE1B2329Q47096141-828E518D-2D51-4B40-AB2F-0B3A7100DCB9Q47880472-66724C9E-6B5B-44F3-B39E-A702A0BFC9ABQ48225984-211C383F-A72B-4D20-9504-091A7D19BA82Q48424721-D1D59B32-6492-4EBE-B764-725FCCF311EEQ48437995-983C7F69-1A31-4369-A4A6-4BCAD468F001Q48605311-44F5623D-9625-4814-BA0B-1DABDF9DC18AQ48961918-B4478E3C-A357-426A-9B4A-3272AC56B47CQ49122235-C2C7564E-DA15-423E-918F-567A68FC9B3BQ50279579-E5F66DE0-2922-4D00-8896-C508CFFDF8ABQ52633801-48397908-56A0-40FB-8A46-C8A644ACF770Q55245469-34CC9FE6-2768-4774-8EE7-C0BC32279687Q55714779-FE78C36A-850A-40F9-9D12-0DCF3A4A2729Q55724201-6076A338-1B99-4952-875C-0BCA2DAA48DFQ57086524-7DE9FEC5-21AC-4A74-A1B7-C7F54612F592Q57299865-FDCBDFD1-B810-4983-80FC-4C184E6109CC
P2860
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@en
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@nl
type
label
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@en
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@nl
prefLabel
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@en
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genotype-specific patterns of ...... ecline in SCA1, SCA3 and SCA6.
@en
P2093
Agnes Juzek
Alexandra Dürr
Anna Lehmann
Bart P van de Warrenburg
Caterina Mariotti
Christoph Linnemann
Heike Jacobi
Marina Grisoli
Massimo Pandolfo
Peter Bauer
P2860
P304
P356
10.1093/BRAIN/AWS369
P407
P50
P577
2013-02-18T00:00:00Z